Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics?


Cancer is a disease in which cellular growth regulatory networks are disrupted. Lesions in well-characterized oncogenes and tumor suppressors often contribute to the dysregulation, but recent work has also uncovered the fundamental importance of enzymes that modulate the acetylation status of chromatin to the initiation or progression of cancer. Histone… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.